Search Results - "Alcaide, Fernando"

Multicentre study on the reproducibility of MALDI-TOF MS for nontuberculous mycobacteria identification.

Authors: Rodriguez-Temporal, David Alcaide, Fernando Mareković, Ivana et al.

Source: Scientific Reports. 1/24/2022, Vol. 12 Issue 1, p1-7. 7p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Reversions of QuantiFERON-TB Gold Plus in tuberculosis contact investigation: A prospective multicentre cohort study.

Authors: Pérez-Recio, Sandra Grijota-Camino, Maria D. Anibarro, Luis et al.

Source: PLoS ONE. 8/30/2023, Vol. 18 Issue 8, p1-8. 8p.

First human isolate of Mycobacterium madagascariense in the sputum of a patient with tracheobronchitis.

Authors: Ballester, Frederic Alcaide, Fernando Pujol, Isabel et al.

Source: Clinical Chemistry & Laboratory Medicine. Feb2013, Vol. 51 Issue 2, pe35-e36. 2p. 1 Chart.

QuantiFERON-TB Gold In-Tube as a Confirmatory Test for Tuberculin Skin Test in Tuberculosis Contact Tracing: A Noninferiority Clinical Trial.

Authors: Muñoz, Laura Santin, Miguel Alcaide, Fernando et al.

Source: Clinical Infectious Diseases. Feb2018, Vol. 66 Issue 3, p396-403. 8p.

High rates of resistance to cephalosporins among viridans-group streptococci causing bacteraemia in neutropenic cancer patients.

Authors: Marron, Anna Carratalà, Jordi Alcaide, Fernando et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). Jan2001, Vol. 47 Issue 1, p87-91. 5p.

Pulmonary Infections with Nontuberculous Mycobacteria, Catalonia, Spain, 1994-2014.

Authors: Santin, Miguel Barrabeig, Irene Malchair, Pierre et al.

Source: Emerging Infectious Diseases. Jun2018, Vol. 24 Issue 6, p1091-1094. 4p. 2 Charts, 2 Graphs.

QuantiFERON^®-TB Gold In-Tube for contact screening in BCG-vaccinated adults: A longitudinal cohort study.

Authors: Muñoz, Laura Gonzalez, Lucia Soldevila, Laura et al.

Source: PLoS ONE. 8/30/2017, Vol. 12 Issue 8, p1-10. 10p.

Towards clinical breakpoints for non-tuberculous mycobacteria – Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution.

Authors: Fröberg, Gabrielle Maurer, Florian P. Chryssanthou, Erja et al.

Source: Clinical Microbiology & Infection. Jun2023, Vol. 29 Issue 6, p758-764. 7p.

Clinical Significance of Indeterminate QuantiFERON-TB Gold Plus Assay Results in Hospitalized COVID-19 Patients with Severe Hyperinflammatory Syndrome.

Authors: Solanich, Xavier Fernández-Huerta, Miguel Basaez, Celeste et al.

Source: Journal of Clinical Medicine. Mar2021, Vol. 10 Issue 5, p918-918. 1p.

Characterization of the embB gene in Mycobacterium tuberculosis isolates from Barcelona and rapid detection of main mutations related to ethambutol resistance using a low-density DNA array.

Authors: Moure, Raquel Español, Montserrat Tudó, Griselda et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). Apr2014, Vol. 69 Issue 4, p947-954. 8p.

Impaired fitness of Mycobacterium tuberculosis resistant isolates in a cell culture model of murine macrophages.

Authors: Rey-Jurado, Emma Tudó, Griselda Borrell, Sònia et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). Oct2011, Vol. 66 Issue 10, p2277-2280. 4p.

Diagnosis of tuberculosis infection by tuberculin skin test and a whole-blood interferon-γ release assay in patients considered for anti–tumor necrosis factor-α therapy

Authors: Casas, Susana Andreu, Ana Juanola, Xavier et al.

Source: Diagnostic Microbiology & Infectious Disease. Sep2011, Vol. 71 Issue 1, p57-65. 9p.

Detection of latent tuberculosis by the tuberculin skin test and a whole-blood interferon-γ release assay, and the development of active tuberculosis in HIV-seropositive persons

Authors: Santin, Miguel Casas, Susana Saumoy, Maria et al.

Source: Diagnostic Microbiology & Infectious Disease. Jan2011, Vol. 69 Issue 1, p59-65. 7p.

Characterization of mutations in streptomycin-resistant Mycobacterium tuberculosis clinical isolates in the area of Barcelona.

Authors: Tudó, Griselda Rey, Emma Borrell, Sònia et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). Nov2010, Vol. 65 Issue 11, p2341-2346. 6p. 1 Diagram, 1 Chart.

Serious Complications of Bacteremia Caused by Viridans Streptococci in Neutropenic Patients with Cancer.

Authors: Marron, Anna Carratala, Jordi Gonzalez-Barca, Eva et al.

Source: Clinical Infectious Diseases. 11/1/2000, Vol. 31 Issue 5, p1126-1130. 5p.

Bacteremic pneumonia in neutropenic patients with cancer.

Authors: Carratala, Jordi Roson, Beatriz Fernández-Sevilla, Alberto et al.

Source: Archives of Internal Medicine. 4/27/98, Vol. 158 Issue 8, p868. 5p. 4 Charts.

GeneXpert® for smear-negative pulmonary tuberculosis: does it play a role in low-burden countries?

Authors: Muñoz, Laura Moure, Raquel Porta, Nuria et al.

Source: Diagnostic Microbiology & Infectious Disease. Mar2013, Vol. 75 Issue 3, p325-326. 2p.